Pure Global AI
ANVISA registration 10287411806Valid until Aug 10, 2036

HUMAN BRAIN NATRIURETIC PEPTIDE (BNP)

ANVISA Registration Number: 10287411806ROCHE DIAGNÓSTICA BRASIL LTDALUMIRADX UK LTDRisk Class III
Verified
Device names
Technical name
HUMAN BRAIN NATRIURETIC PEPTIDE (BNP)
View exact technical-name matches →
PT: PEPTÍDEO NATRIURÉTICO CEREBRAL HUMANO (BNP)
Commercial name
Família LumiraDx NT-proBNP
View exact commercial-name matches →
Risk class
Class III
Registration details
Registration Number
10287411806
Process Number
25351091959202634
CNPJ
30280358000186
Company information
Registration Holder
ROCHE DIAGNÓSTICA BRASIL LTDA
Manufacturer
LUMIRADX UK LTD
Manufacturing Country
United Kingdom
PT: REINO UNIDO
Dates and status
Publication Date
Aug 10, 2026
Validity
10/08/2036
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for HUMAN BRAIN NATRIURETIC PEPTIDE (BNP) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10287411806 and manufactured by LUMIRADX UK LTD. The registration is held by ROCHE DIAGNÓSTICA BRASIL LTDA with validity until Aug 10, 2036.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.